Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan
Abstract Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Methods: A descriptive, retrospective study was conducted between 2011 and 2015. The analysis included: anti-inflammatory and antirheumatic products non-steroids, opioid analgesics and other analgesics and antipyretics. Data are converted into DDD/100 bed-days to analyze consumption trends. Main outcome measure: assessment of the analgesic consumption after the implementation of a pain performance improvement plan. Results: Overall, non-steroidal anti-inflammatory and antirheumatic products consumption decreased in 24.8 DDD/100 bed-days (-28.3%), accounting for most of the total analgesic consumption decrease (-13%) and total cost (-44.3%). Opioid consumption increased markedly from 22.3 DDD/100 bed-days in 2011 to 26.5 DDD/100 bed-days in 2015 (+18.9%). In 2011, the most consumed opioid was morphine (8.6 DDD/100 bed-days). However, there was an increasing trend in fentanyl consumption (from 8.1 to 12.1 DDD/100 bed-days in 2015), which resulted in fentanyl replacing morphine from the most consumed opioid in 2015 (12.1 DDD/100 bed-days). In 2015, the group of other analgesics and antipyretics represented 46.2% of the total analgesic consumption. Acetaminophen was the most commonly consumed analgesic drug (53.2 DDD/100 bed-days in 2015) and had the highest total cost, it represented 55.4% of the overall cost in 2015. Conclusion: Opioid consumption showed an increasing trend during the 5 year period, with fentanyl replacing morphine as the most used opioid. In general, analgesics diminished use was due to the decreasing trend of consumption of non-steroidal anti-inflammatory and antirheumatic products.
Main Authors: | , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Anestesiologia
2019
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000300259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0034-70942019000300259 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0034-709420190003002592019-08-06Trends in hospital consumption of analgesics after the implementation of a pain performance improvement planMonje,BeatrizGiménez-Manzorro,ÁlvaroOrtega-Navarro,CristinaHerranz-Alonso,AnaSanjurjo-Sáez,María Analgesic Consumption Pain Opioid Abstract Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Methods: A descriptive, retrospective study was conducted between 2011 and 2015. The analysis included: anti-inflammatory and antirheumatic products non-steroids, opioid analgesics and other analgesics and antipyretics. Data are converted into DDD/100 bed-days to analyze consumption trends. Main outcome measure: assessment of the analgesic consumption after the implementation of a pain performance improvement plan. Results: Overall, non-steroidal anti-inflammatory and antirheumatic products consumption decreased in 24.8 DDD/100 bed-days (-28.3%), accounting for most of the total analgesic consumption decrease (-13%) and total cost (-44.3%). Opioid consumption increased markedly from 22.3 DDD/100 bed-days in 2011 to 26.5 DDD/100 bed-days in 2015 (+18.9%). In 2011, the most consumed opioid was morphine (8.6 DDD/100 bed-days). However, there was an increasing trend in fentanyl consumption (from 8.1 to 12.1 DDD/100 bed-days in 2015), which resulted in fentanyl replacing morphine from the most consumed opioid in 2015 (12.1 DDD/100 bed-days). In 2015, the group of other analgesics and antipyretics represented 46.2% of the total analgesic consumption. Acetaminophen was the most commonly consumed analgesic drug (53.2 DDD/100 bed-days in 2015) and had the highest total cost, it represented 55.4% of the overall cost in 2015. Conclusion: Opioid consumption showed an increasing trend during the 5 year period, with fentanyl replacing morphine as the most used opioid. In general, analgesics diminished use was due to the decreasing trend of consumption of non-steroidal anti-inflammatory and antirheumatic products.info:eu-repo/semantics/openAccessSociedade Brasileira de AnestesiologiaRevista Brasileira de Anestesiologia v.69 n.3 20192019-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000300259en10.1016/j.bjane.2018.12.007 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Monje,Beatriz Giménez-Manzorro,Álvaro Ortega-Navarro,Cristina Herranz-Alonso,Ana Sanjurjo-Sáez,María |
spellingShingle |
Monje,Beatriz Giménez-Manzorro,Álvaro Ortega-Navarro,Cristina Herranz-Alonso,Ana Sanjurjo-Sáez,María Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
author_facet |
Monje,Beatriz Giménez-Manzorro,Álvaro Ortega-Navarro,Cristina Herranz-Alonso,Ana Sanjurjo-Sáez,María |
author_sort |
Monje,Beatriz |
title |
Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
title_short |
Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
title_full |
Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
title_fullStr |
Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
title_full_unstemmed |
Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
title_sort |
trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan |
description |
Abstract Background: Pain management committee established a pain performance improvement plan in 2012. Objectives: The aim of the study was to assess the trends in analgesic consumption in a tertiary teaching hospital and the associated economic impact. Methods: A descriptive, retrospective study was conducted between 2011 and 2015. The analysis included: anti-inflammatory and antirheumatic products non-steroids, opioid analgesics and other analgesics and antipyretics. Data are converted into DDD/100 bed-days to analyze consumption trends. Main outcome measure: assessment of the analgesic consumption after the implementation of a pain performance improvement plan. Results: Overall, non-steroidal anti-inflammatory and antirheumatic products consumption decreased in 24.8 DDD/100 bed-days (-28.3%), accounting for most of the total analgesic consumption decrease (-13%) and total cost (-44.3%). Opioid consumption increased markedly from 22.3 DDD/100 bed-days in 2011 to 26.5 DDD/100 bed-days in 2015 (+18.9%). In 2011, the most consumed opioid was morphine (8.6 DDD/100 bed-days). However, there was an increasing trend in fentanyl consumption (from 8.1 to 12.1 DDD/100 bed-days in 2015), which resulted in fentanyl replacing morphine from the most consumed opioid in 2015 (12.1 DDD/100 bed-days). In 2015, the group of other analgesics and antipyretics represented 46.2% of the total analgesic consumption. Acetaminophen was the most commonly consumed analgesic drug (53.2 DDD/100 bed-days in 2015) and had the highest total cost, it represented 55.4% of the overall cost in 2015. Conclusion: Opioid consumption showed an increasing trend during the 5 year period, with fentanyl replacing morphine as the most used opioid. In general, analgesics diminished use was due to the decreasing trend of consumption of non-steroidal anti-inflammatory and antirheumatic products. |
publisher |
Sociedade Brasileira de Anestesiologia |
publishDate |
2019 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-70942019000300259 |
work_keys_str_mv |
AT monjebeatriz trendsinhospitalconsumptionofanalgesicsaftertheimplementationofapainperformanceimprovementplan AT gimenezmanzorroalvaro trendsinhospitalconsumptionofanalgesicsaftertheimplementationofapainperformanceimprovementplan AT orteganavarrocristina trendsinhospitalconsumptionofanalgesicsaftertheimplementationofapainperformanceimprovementplan AT herranzalonsoana trendsinhospitalconsumptionofanalgesicsaftertheimplementationofapainperformanceimprovementplan AT sanjurjosaezmaria trendsinhospitalconsumptionofanalgesicsaftertheimplementationofapainperformanceimprovementplan |
_version_ |
1756376378784088064 |